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Abstract
The primary care office is an ideal setting and the front gate for screening young adults
for chlamydia infection. Chlamydia is the most common sexually transmitted infection in the
US and sexually active women aged 24 and younger are at the highest risk for having it (Centers
for Disease Control and Prevention [CDC], 2016). Screening is simple and effective and can be
completed through a urine test. Treatment is straightforward and involves a one-time dose of
antibiotic medicine. Untreated infections in women can lead to pelvic inflammatory disease
(PID), chronic pelvic pain, infertility, and life-threatening ectopic pregnancies (Papp, Schachter,
Gaydos, & Pol, 2014). Despite the simplicity of managing this specific sexually transmitted
infections, screening occurs in only about half of these women (CDC, 2013). The advent of the
electronic medical record (EMR) has helped to improve healthcare, for example medication
errors have drastically improved (The Office of the National Coordinator for Health Information
Technology, (ONC), 2019). For my DNP project, I leveraged the technologic potential of the
EMR’s in order to improve chlamydia screening. This technology stands to identify more
infections and earlier, facilitate prompt treatment with a simple and cheap medication, improve
the quality of lives of US citizens, and preserve precious healthcare resources by reducing the
incidence of chronic conditions.
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Problem Description
Chlamydia is the most common sexually transmitted infection reported in the United
States and it is estimated that 1 in every 20 sexually active females aged 13 to 24 is infected
(Torrone, Papp, Weinstock, & Centers for Disease Control and Prevention, [CDC],
2014). Chlamydia is a bacterial infection that is often asymptomatic, thus most of those infected
are unaware and do not seek treatment, while being able to spread it silently. In 2012 there were
more than 1.4 million cases that were reported to the CDC, however, because most infections are
asymptomatic the true incidence is hard to accurately estimate (Centers for Disease Control and
Prevention, 2015). There is a disproportionate amount of infection in minorities as well as those
in low socioeconomic status (Owusu-Edusei, Chesson, Leichliter, Kent, & Aral, 2013).
Untreated infections in women can lead to pelvic inflammatory disease, chronic pelvic pain,
infertility, and life-threatening ectopic pregnancies (Papp, Schachter, Gaydos, & Pol, 2014).
People between the ages of 13 and 24 years old are considered to be in adolescence and
early adulthood. This period of life includes physical, psychological, cognitive, emotional,
social, sexual, and identity development within the framework of social expectations, change,
and increased risk-taking (Jaworska & MacQueen, 2015). Behaviorally, adolescents are more
likely to engage in high-risk sexual behavior such as concurrent sex partners or sex without a
condom. This is due in part to the fact that the prefrontal cortex, responsible for executive
function, is still developing through adolescence (Shannon & Klausner, 2018). Furthermore,
experts in the field of adolescent health have long recognized that many of the greatest threats to
health and wellness for this population occurs as a result of risky behaviors, including unsafe sex
(resulting in high rates of unplanned pregnancies as well as sexual transmitted disease) (Bitzer,
Sultan, Creatsas, & Palacios, 2014). Early adulthood is the transition period between adolescence
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and adulthood and is important as it sets the stage for later adult life. Young adults (aged 19 to
24) often develop healthy lifestyles but are not risk-free. Identified risks include the use of
alcohol, tobacco, and drugs (and driving under the influence) and risky sexual behavior persists
from adolescence and even peaks in this age period (Scales et al., 2015). This results in males
and females, aged 24 years old and younger, being at an increased risk for acquiring chlamydia.
The United States Preventive Services Task Force (USPSTF) is an independent group of
national experts who research and develop recommendations for clinical preventive
services. Their mission is to provide evidence-based recommendations on preventive services to
primary care physicians who deliver preventive care (Krist, Bibbins-Domingo, Wolff, & MabryHernandez, 2018). One of the recommendations put forth by the USPSTF is to perform annual
chlamydia screening for all sexually active females aged 24 and younger (USPSTF,
2014). Several other professional organizations have developed and endorse similar screening
guidelines (Table 1). Based on these recommendation Medicare, Medicaid, and private health
insurance plans cover the cost of screening and treatment without cost-sharing (CDC, 2020).
Table 1 - Recommendations for Chlamydia Screening
Organization
Recommendations
Screen annually for all sexually active females aged 24
United States Preventive Services Task Force
years and younger
Screen annually for all sexually active females aged 25
The Centers for Disease Control and Prevention
years or younger
Screen annually for all sexually active females aged 24
American Academy of Family Physicians
years and younger
Screen annually for women younger than 25
American College of Obstetricians and Gynecologists
American Academy of Pediatrics

Screen annually for women younger than 25

According to the American Academy of Family Physicians (AAFP), primary care
practice provides health promotion, disease prevention, health maintenance, counseling, patient
education, diagnosis and treatment of acute and chronic illnesses within a variety of care settings
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(American Academy of Family Physicians, 2020). Despite primary care being the responsible
and optimal setting, effective patient screening for targeted populations can be challenging
within a busy primary care setting. Primary care appointments are typically 15 minutes in
duration, and the majority of appointment include either a chronic condition or a new complaint
(CDC, 2019). Insurance data from 2014 reflects this challenge showing that only 47% of
sexually active women under the age of 24 with commercial health insurance and about 55%
with Medicaid were screened for chlamydia (CDC, 2013).
Native American Health Center (NAHC) is a Federally Qualified Health Center (FQHC)
located in the Fruitvale area of Oakland, California. An FQHC is a community-based
organization that provides comprehensive primary and preventative care, including health, oral,
and mental health/substance abuse services to all people regardless of health insurance status or
ability to pay (Rural Health Information Hub, 2019). The FQHC is considered a critical
component of the health care safety net and functions to provide services to underserved
populations. Native American Health Center is a primary care outpatient community clinic that
serves a diverse urban population. This population consists of: 21% Native American, 20%
African American, 47% Latino, 12% Euro American, 9% Asian/Pacific Islander, and 1%
unknown (Native American Health Center, 2010). The languages spoken at the clinic include
English, Spanish, Mam, Chinese, and Tongan.
A needs assessment was performed at NAHC in May 2019 with chlamydia screening
rates being evaluated for the years of 2018 to 2019. Screening rates for this high-risk and
underserved population of sexually active females aged 24 and younger was found to be 14%,
whereas the national average based on Medicare data in this population is 55%. A GAP analysis
reveals three areas where the current state of the organization does not reflect best practice.
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First, staff knowledge and confidence regarding interaction with patients around the topic of
chlamydia screening is questionable and there is lack of evidence that periodic education on
screening guidelines, symptoms, treatment, and common questions is being provided. Best
practice would involve periodic education for staff members to raise awareness and knowledge.
A solution to this gap would be to develop and provide an education module for staff to teach,
reinforce, and update knowledge regarding aspects of care surrounding screening and treatment.
Second, there are cultural and educational barriers with patients on effective chlamydia screening
in the clinical setting. Best practice would be for staff to effectively communicate and educate,
answers questions about, and recommend annual screening to high-risk patients. A solution to
this gap involves creating a survey to assess staff knowledge and confidence surrounding the
topic of chlamydia, and to conduct a secondary post-education survey to reassess staff
knowledge and confidence after the educational content has been provided. Finally, there is an
absence of any formal system to remind providers of high-risk populations and frequency for
chlamydia screening. Best practice includes the availability of a convenient and accessible
reminder system for staff to reference and identify high-risk populations as well as chlamydia
screening guidelines. A solution for this gap involves the initiation of an electronic
notification/reminder system to alert providers when clinic patients are considered high-risk and
due for chlamydia screening. The aim of this project, referred to as the Chlamydia Screening
Improvement Project (CSIP), is to improve screening rates for chlamydia infection within a
primary care setting, by implementation of an electronic notification system and education-based
protocol, for the high-risk patient population of sexually active females aged 24 years old and
younger.
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Available Knowledge
The search inquiry was completed utilizing the electronic medical databases PubMed,
CINAHL Complete, Scopus, and included the keywords “chlamydia”, “screening”, and “primary
care”. Inclusion criteria were set to include only research conducted over the past 10 years (June
2010 through June 2020), English-language studies, peer-reviewed journals, and article types
that included systematic reviews, randomized controlled trials, and reviews. The search was
conducted using the described keywords with appropriate filters yielded 301 articles. Articles
whose title and abstract were based on retesting after infection and treatment, partner
notification, protocols for screening, opportunistic testing, qualitative-based articles, testing in
the home or Emergency Departments setting, or whose focus was on men or transgender were
excluded. Secondary review included the reference lists in articles that met search criteria.
Furthermore, guidelines for chlamydia screening were reviewed through a general internet search
of qualifying organizations. The Johns Hopkins Nursing Evidence-Based Practice Evidence
Appraisal Tool (JHNEBP) was utilized to ascertain clinical relevance and validity. Seven
articles were identified for the following review of evidence and a summary of these articles are
provided in evaluation table format (Appendix C).
Keegan, Dledrich, & Pelpert (2014) conducted a meta-analysis that evaluated screening
recommendations, screening tests, barriers to screening, and management for chlamydia
infection. There were two randomized controlled trials reviewed in this meta-analysis that
supported annual chlamydia screening. The first looked at high-risk women in Seattle and found
that the risk of pelvic inflammatory disease (PID) was reduced by 50% in women who
completed screening, and treatment, if necessary, within a one-year period. The other looked at
high school students in Denmark who were mailed information on chlamydia, and encouraged to
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visit their physician for free screening. This intervention was associated with a 50% reduced risk
of PID (4.2% vs. 2.1%, P = 0.045) at one year. Keegan, Dledrich, & Pelpert (2014) noted that
based on these two studies, in 2007 the US Preventative Services Task Force (USPSTF)
recommended annual chlamydia screening for all sexually active non-pregnant females aged 24
and younger. There are different methods to test for chlamydia infection. It was noted that cell
culture was once the gold standard in identification based on its superior specificity, however,
the current standard diagnostic and screening test has changed to nucleic acid amplification test
(NAATs). The use of NAATs has superior sensitivity and specificity while allowing for
additional screening options, such as urine collection and vaginal swab. The vaginal swab
method of testing had the highest sensitivity (86% and 97.2%), is the most preferred by patients,
and is now the CDC recommendation for testing method (Keegan, Dledrich, & Pelpert (2014).
While screening rates have increased over the years, potentially due to the development of
NAAT allowing for urine or vaginal swab testing, a large portion of women are still not being
screened.
Barriers to screening were evaluated by Keegan, Dledrich, & Pelpert (2014) and for
providers barriers identified included being a male provider, having the perception that
chlamydia prevalence was low, being a solo practitioner, practicing in a rural setting, and
practicing in an area with few minority patients. This meta-analysis found that a combination of
educational outreach and financial incentive increased practitioner’s involvement with chlamydia
screening and led to a significant increase in the number of tests performed. For patients,
barriers to screening included a lack of knowledge related to its asymptomatic nature, possible
long-term morbidity of infection, as well as stigma related to screening and receiving a positive
diagnosis. Furthermore, it was found that patients who were minority race/ethnicity, low socio-
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economic status, and lack of insurance had decreased screening. Mail-based chlamydia
information with a mail-back sampling kit were 2 to 3 times more likely to be diagnosed and
treated for chlamydia than those receiving the usual standard of care. Also, the advent of NAAT
testing has allowed for alternative testing options (i.e. urine and vaginal swab), which was found
to be much more comfortable for patients, allowed for self-collection, and can be done either at
home or in the clinic.
Treatment of infection was evaluated by Keegan, Dledrich, & Pelpert (2014) and looked
at treatment from a medication as well as a partner-treatment standpoint. It found that both
azithromycin and doxycycline have comparable cure rates. While azithromycin is a one-time
oral treatment, doxycycline requires pills to be taken twice daily for 7 days. Based on the
concern that many patients may not complete all seven days of a course of doxycycline, the CDC
recommends the use of 1 gram of azithromycin orally in a single dose (CDC, 2016). Alternative
treatments with erythromycin or fluoroquinolones are available for patients who are allergic to,
or unable to tolerate, preferred treatment. A thorough sexual history should be performed on all
patients screening positive for chlamydia and when the patient receives a prescription for
treatment, additional medication should be provided for treatment of all sexual contacts within
the preceding 60 days. The provision for providing additional prescriptions and medication
instructions for patients to give to their sexual partners without requiring them to be seen by a
physician is the cornerstone of Expedited Partner Therapy (EPT). Currently, the use of EPT is
legal in the state of California and may be provided by physicians, nurse practitioners, certified
midwives, and physician assistants (CDC, 2007). Reinfection is very common, for reasons
including re-infection from untreated partners, infection from subsequent partners, persistent
infection, and failure to complete treatment (Heijne, Althaus, Herzog, Kretzschmar, & Low,
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2011). It is recommended by Keegan, Dledrich, & Pelpert (2014) that patients testing positive be
retested in 3 months to ensure the infection is cleared.
The strengths of the study by Keegan, Dledrich, & Pelpert (2014) include the review of
randomized controlled trials and meta-analysis, as well as linking data to recommendations made
by CDC and the USPSTF. It considered all major aspects of chlamydia from a primary care
standpoint as well as highlighting key recommendations to improve screening. Unfortunately,
the study does not expand on barriers to screening and the recommendations for financially
incentivizing providers to enhance screening is not always feasible in areas serving low socioeconomic and minority populations.
Interventions to increase rates for chlamydia screening in primary care were evaluated by
Guy et al. (2011) in a systematic review. In total there were 16 interventions with 15 of them
targeting females. Of these 15 interventions for females, 6 were associated with statistically
significant increases in chlamydia screening rates. The 6 interventions included 1) a multifaceted quality improvement program that included urine collection from all patients at
registration, 2) linking screening to routine PAP smears, 3) computer notification system for
doctors, 4) education workshop for clinical staff, 5) internet based continuing medical education,
and 6) offering free sexual health consultations to patients. The multi-faceted quality
improvement program included a 4-stage clinical improvement initiative which included
capacity building, development of a clinic flow-chart, monthly meetings to identify screening
barriers and strategies to overcome them, development of performance indicators, and a
universal urine specimen collection from all patients included in the program at the time of
registration. This quality improvement program demonstrated an improvement in screening rates
from 21% to 65% with effects that were sustainable for 18 months and shows that a multi-
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faceted approach to improving chlamydia screening rates can be effective. The second
intervention included linking chlamydia screening to PAP smears in a randomized controlled
trial in Australia resulted in a small but significant increase in screening from 4.5% to 6.9%. The
third intervention included the use of a computer notification for physicians, was based on a
randomized controlled trial in Australia, and the results demonstrated an increase in chlamydia
screening from 10.6% to 12.2%. The fourth intervention was based on an education workshop
for staff and resulted in a 33% increase in screening rates with effects that lasted for 10 months.
The fifth intervention was based on continuing medical education for physicians which results in
an increase in chlamydia screening rates from 12.4% to 15.5%. The sixth intervention involved
offering free sexual health consultations to patients in New Zealand and this intervention resulted
in increased screening rates from 13.2% to 16.8%. Each of these six interventions demonstrated
statistically significant improvement to chlamydia screening and can be helpful in identifying
solutions for increasing chlamydia screening.
Strengths of the study included the focus on evaluating interventions aimed at improving
chlamydia screening rates and included a review of high quality RCTs with large patient
populations (Guy et al., 2011). Also, cost and complexity of implementation were not exclusion
criteria, thus many different types of interventions were reviewed. Of note, two of the
interventions reviewed in this study (computer notification and education workshop for clinical
staff) are components within this quality improvement project. Limitations of the study include
the lack of screening for a specific high-risk population (sexually active females aged 24 and
younger), the linking of chlamydia screening to PAP smears excludes females under 20 who are
ineligible for PAP smears. It was also noted that the development of an interactive workshop for
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staff education would require significant staff resources and would be challenging to roll out on a
large scale.
McDonagh and colleagues (2018) completed a systematic review to identify barriers and
facilitators to chlamydia testing for young people as well as providers within a primary care
setting. Thirty-nine papers met the review’s inclusion criteria with 14 focusing on patients and
25 focusing on providers. The Capability, Opportunity, and Motivational model of behavior
(COM-B) was used to identify the facilitators and barriers for chlamydia screening. Barriers and
facilitators were identified at the patient, provider, and service level. This review helped clarify
the complexity of chlamydia testing behavior while also providing guidance on how to improve
chlamydia testing within a primary care setting.
Barriers to care limit or prevent people from receiving good quality health care. Several
barriers to chlamydia screening were identified and broke down by patient, provider, or facility
by McDonagh and colleagues (2018). For patients, barriers include a lack of
education/knowledge/awareness, beliefs regarding risks, embarrassment, fear of receiving a
positive result, and stigma. For providers, barriers include a lack of training and skills,
knowledge and awareness, forgetfulness, the perception of patients, the challenge of discussing
screening, and effects on the doctor/patient relationship. For facilities, barriers include lack of
practice nurse involvement, lack of testing guidance, unattainable targets, time-constraint, testing
based on behavior, costs of testing, and testing policy/cultural norms.
Facilitators are things that provide support to individuals or groups of people in order to
achieve beneficial change. McDonagh and colleagues (2018) also identified several facilitators to
chlamydia screening and broke them out by patient, provider, or facility. For patients,
facilitators include increasing knowledge/education/awareness, the belief that testing was
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responsible/mature/healthy, worries of an asymptomatic infection, and easy availability for
testing. For providers, facilitators include skills-based training, increasing
knowledge/awareness/education, increasing confidence, modes of testing, and the consultation
context. For facilities, facilitators include involving practice nurses, prompts and reminders,
reward and incentive programs, feedback on efforts, promotional material, and testing policy.
McDonagh and colleagues (2018) highlight the complex nature of screening for
chlamydia within the primary care setting. Time limitation was identified as a barrier that
spanned the patient, the provider, as well as the facility. Standard primary care doctor
appointments can be as short as 15 minutes in length, covering primary complaints, management
of chronic conditions, and all health maintenance which can severely limit the amount of time
available to discuss chlamydia screening. Normalization was a component found to be a
facilitator that also spanned the patient, provider, and facility. Other components were found to
be both a barrier and facilitator. The involvement of reception staff could improve screening by
addressing workload and time constraints, but at the same time they are ill-equipped to answer
questions and patients found the reception area unacceptable for initiating testing. Themes that
emerged from the study included the need to normalize testing as universal and to embed it
within routines, preserve patient privacy regarding sexual history and screening, address timeconstraints, and offer testing in a context that addresses potential stigma. Other aspects were
found to be more directly related. Lack of provider training and knowledge were associated with
less confidence in conducting screening. Forgetfulness was related to a lack of a reminder
system. Finally, patient’s perceived risk was mediated through awareness and education on
chlamydia.

INCREASING CHLAMYDIA SCREENING IN PRIMARY CARE

15

Strengths of the review by McDonagh and colleagues (2018) include its comprehensive
analysis of multi-level as well as theoretical barriers and facilitators associated with chlamydia
screening. By implementing clinic-based interventions that overcome barriers or leverage
facilitators, projects designed to improve chlamydia screening stand a much higher chance of
success. It is also based on the COM-B model which develops a framework for evaluating and
explaining chlamydia testing within the primary care setting and can serve as a foundation for
future interventions. Limitations of this review include the lack of background, demographics,
or testing patterns of the providers or facilities, which would have provided context for the input
of staff. Also, patients in this review may or may not have been offered chlamydia test, and if
they had, it could have been in any setting. Therefore, feelings and input at the time of interview
may not represent what would actually happen if they were offered a test at their primary care
clinic.
Wong et al. (2019) conducted a systematic review evaluating interventions used to
improve chlamydia screening; assessing effectiveness while also evaluating variabilities within
the interventions which can make it difficult to determine effectiveness. The socioecological
model was used to organize interventions, including classifications for individual, interpersonal,
organizational, community, and policy. At the level of the individual and interpersonal, results
demonstrate that providing home-based chlamydia screening tests was an effective solution to
increase screening but identified its cost-effectiveness as a potential barrier to success and
requiring further research. At the organizational level interventions were further broken down
into low-cost (<$1,000), moderate-cost ($1,000 to $10,000) and high-cost (>$10,000). Effective
low-cost interventions included strategic collection cup placement, routine collection during
consultations, and use of an electronic health record notification. Moderate-cost interventions
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that were found to be effective included use of postcards and telephone calls. High-cost
interventions found effective were based on dedicated staff screening and offering free sexual
health consultations. Challenges for implementing effective solution at the organizational level
include the lack of protocols for obtaining urine samples, insufficient knowledge about
chlamydia and urine-based tests, and reluctance of staff to engage in screening adolescents for
sexually transmitted infections. At a community level this review found that screening within a
juvenile detention/correctional facility, or an educational setting is an effective method for
screening within high prevalence settings. It found that outreach programs may achieve high
participation rates but suffer from limited reach, and that the most effective solutions are mostly
not publicly available. At the policy level this review identified that providing education, either
through an educational package, a health advisor to increase awareness and train staff, or an
internet-based medical education program, was an effective method of increasing chlamydia
screening while noting that for a variety of reasons many clinicians are hesitant to screen
sexually active asymptomatic female patients.
CSIP was able to leverage research from the Wong et al. (2019) review demonstrating
that use of an electronic health record notification system is an effective and cost-efficient
solution for increasing rates of chlamydia screening. Recommendations for an educational
package for practitioners and the use of internet-based education can help to improve knowledge
and confidence regarding chlamydia were incorporated into the project and may also serve to
address concerns brought up in the review identifying insufficient knowledge about chlamydia
for the individual patient as knowledgeable staff members may be able to field questions and
educate patients. Future research would benefit from further evaluating home testing kits in
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order to determine when cost becomes effective and to further evaluate the impact use of a
home-testing kit can have on chlamydia screening rates.
McNulty et al. (2013) conducted a prospective cluster randomized control trial to
evaluate if a structured complex intervention increased chlamydia screening rates in a primary
care setting. Randomizing can be difficult to conceal when evaluating an educational
component, thus a modified Zelen design was used and overcomes this concern by not informing
any participants they are in a trial. The multifaceted complex intervention is based on a
cognitive theory such as the theory of Planned Behavior which has been demonstrated as
effective to help change behavior. This RCT targeted patients aged 15 to 24 years old and
involved 160 primary care offices: with 80 in the intervention group and 80 in the control group.
The intervention was broken down into different components to address aspects of the
theory of planned behavior such as changing personal attitudes, subjective norms, and behavior
controls. In the area of changing personal attitudes, interventions included a workshop showing
how common chlamydia is and the benefits of testing asymptomatic populations, develop testing
targets, provide feedback/champions/screening performance through monthly newsletters,
providing a certificate of training as well as a certificate of personal development. In
establishing subjective norms interventions included an invitation for all staff to participate in the
workshop, providing posters for the clinic that state “WE are a chlamydia screening practice”,
facilitating teamwork through inclusion of chlamydia testing as a standing agenda in practice
meetings, the publishing of a monthly newsletter providing information on screening rates, and
adding a pop-up reminder for targeted population in order to normalize the offer. In the area of
behavioral controls, interventions included a workshop with protected learning time to improve
staff knowledge and inspire self-confidence to offer screening, registration to provide invitation
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cards for patients to ask for screening, adding chlamydia screening to order templates for
different consultations such as (i.e. contraception/asthma/travel/etc), and to offer a web-based
education module to allow those who cannot make the workshop to still undertake training and
receive a certificate. The use of this complex intervention led to an overall 76% increase in
chlamydia screening across all practices who received the intervention as compared to those that
did not use the intervention. Absolute testing rates for 15- to 24-year-old patients increased from
2.43 to 4.34 per 100 patients in the intervention group compared with controls that increased
from 2.61 to 3.00 per 100 patients, unadjusted ratio 1.66 (CI 1.1 to 2.5). In the 34 practices that
utilized electronic notifications as part of their intervention results demonstrated the testing rate
was 2.81 times as great as in the control group (RR 2.81, 95% CI 1.91 to 4.13, p<0.001).
Results from the RCT by McNulty et al. (2013) support the idea that CSIP can see
improvement in screening rates through use of education and electronic notification. A strength
of the study was that it was a randomized control trial, which evaluated and demonstrated a
significant improvement in screening rates through use of electronic notification system. In
evaluating this data for use in CSIP, a weakness in the trial was that the education was integrated
into the complex intervention in such a way that it became challenging to extract the degree to
which the education component affected screening rates as compared to, for example, the posters
that state “WE are a chlamydia screening practice”. As the only aspect of the intervention
reporting detailed data was the electronic notification, moving forward it would be beneficial to
parse out how much of an impact each portion of the complex intervention had on the outcome
measure.
Karas et al. (2018) conducted a retrospective review evaluating the impact of pop-up
alerts and education on chlamydia screening rates in female patients aged 13 to 21 years old who
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are presenting for preventative care. The review was conducted across a large network of 27
pediatric primary care offices that serve urban, suburban, and rural areas within the US. The
intervention was based on a clinical decision support (CDS) which is considered to be a process
of enhancing health-related decisions and actions with pertinent, organized clinical knowledge
and patient information to improve both health and healthcare delivery. This is part of the CDS
5 Rights framework which asserts that interventions must provide the right information, to the
right people, via the right channels, in the right format, and at the right point in the workflow.
The primary goal of the intervention was to increase chlamydia screening rates in sexually active
high-risk females. Secondary goals included increasing provider awareness of screening
guidelines, incorporating CDS with appropriate treatment, and provide recommendations for
follow-up.
The intervention was incorporated in the EPIC electronic medical record system. When
the patient chart was opened in EPIC it would scan the patient’s health record for any indication
of sexual activity, including sexually-related diagnosis in the problem list, indication of sexually
activity in the social history, or mention of sexual activity in the history of presenting illness.
EPIC would then scan for a screening order within the prior year and if it did not exist EPIC
would activate an alert that the patient was a candidate from screening. The provider then had
the option to open an order set that contained appropriate screening labs and billing diagnosis. In
conjunction with the pop-up, this intervention also provided an educational component which
included 2 presentations by an adolescent medicine specialist and a quarterly newsletter
distributed to the medical offices for 2 years. Rates for screening in the year prior the
intervention were at 2.4% and increased to 5.01% in the year after the intervention (p<0.01).
Overall, the proportion of screened patients before and after the intervention was statistically
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different (OR=2.143, 95% CI 1.833 to 2.504), which means the odds of a sexually active female
being screened after the intervention was 2.143 times higher than before the intervention.
This review and intervention are very similar in structure to CSIP and the results support
the likelihood of success with CSIP. A strength of the review is that the pop-up notification
provided an easy link to opening an order set which conveniently provides the correct screening
test as well as adjunct order (i.e., retest in 3 months) for the provider to acknowledge. This saves
additional time, increases convenience, and decreases the chances of an incorrect or missed
screening order. CSIP did not include this and future QI project would benefit from including
this and evaluating how it impacts screening rates. Also, the use of a quarterly newsletter
improves awareness of chlamydia screening for providers within the office but it’s effects might
be best utilized in a setting with multiple offices. The use of an adolescent specialist to provide
education could be seen as a strength but in the setting of Covid, where remote access education
was necessary, the benefit of using a specialist capable of answering questions and giving more
in-depth information and richer context was not possible.
Ursa, Greenberg, & McKee (2019) conducted a case study looking at the use of Plan-DoCheck-Adjust (PDCA) as a framework for quality improvement to improve chlamydia screening
in women aged 16 to 24 years old. The use of chlamydia screening was used because of the
health burden that the infection poses, the availability of non-invasive screening tests, success of
treatment and the institution’s low rates screening which needed improvement. The project was
a multidisciplinary collaboration (i.e., family medicine, internal medicine, pediatrics, obstetrics
and gynecology, and the University Health Service) within the University of Michigan Health
System, which is an academic institution in the Midwest United States over a 1-year period. The
intervention included a workflow review, educational material, and clinical decision support tool
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that was integrated into the Electronic Medical Record (EMR) system. Data collection included
outputs from the EMR as well as interviews with clinicians and staff to understand the current
state and challenges of chlamydia screening. The PDCA process for workflow review involves
nine-steps which include 1) Assemble the team, 2) Identify the problem, 3) Prepare, 4) Set a
goal, 5) Identify barriers, 6) Develop a solution, 7) Pilot, 8) Large scale rollout, and 9) Assess
and modify. The educational material was created for staff, patients, and parents and explained
the importance of screening, the process of screening, and how notifications of results and
treatment works. The clinical decision support tool consisted of an alert that displayed in an area
of the EMR called “best practice advisories”. Screening rates for this population was at 29% and
results of this QI project demonstrated that after 1-year rates of screening had increased to 60%.
This project incorporated electronic notifications through the use EPIC and notifications
were placed in an area called “best practice advisories”, which is the same EMR and
implementation method used in CSIP, with similar outcomes. A weakness of this case study was
the lack of detailed information on the educational component. Research has demonstrated that
education is effective raising awareness, increasing knowledge, and inspiring confidence. Thus,
it is likely that the educational component of this intervention was instrumental in the results
demonstrated. Future studies would benefit from a more detailed review of the education in
order to see how details of setting, content and delivery can affect project outcomes.
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PICOT Question
For sexually active females aged 24 and younger, does use of an electronic notification
system with targeted education improve screening rates for chlamydia, as opposed to the
standard care model, over a one-year period.
Rationale / Framework
Despite strong recommendations from several professional organizations, advances in
readily available knowledge (i.e. internet) for the general public, as well as government funding
to cover the costs of screening and treatment for those in underserved and low socio-economic
communities, overall rates for chlamydia screening remains low. Research demonstrates there
are important gaps in patient knowledge, self-reported practices in primary care providers, time
constraints, and the lack of a formal reminder system may contribute to low chlamydia testing
rates and suboptimal management of infection (Lorch et al., 2013). By implementing CSIP, that
leverages technological advances in combination with education supported by Kotter’s change
management model, identified gaps can be filled to improve the health and wellness of a
population that represents the next generation of mothers. Sexually active adolescent females
living in underserved and low socio-economic communities have unique and multi-faced
challenges with maintaining health and wellness. Members of this target population are typically
unaware of the possibility or risk of an asymptomatic infection. This lack of awareness can lead
to lifelong sequalae and place a large burden on the healthcare system and society in general.
The goal with CSIP is to improve chlamydia screening within an underserved population,
resulting in increased health and wellness within the community.
Managers in today’s healthcare system are in an extremely challenging position as they
strive to maintain a competitive edge while leading the organization through constant change.
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Kotter’s change management model can be utilized for this project and is based on a dynamic,
non-linear 8-step approach to implementing change. This model includes 1) increasing urgency,
2) build guiding teams, 3) get the vision right, 4) communicate for buy-in, 5) enable action, 6)
create short-term wins, 7) don’t let up, and 8) make it stick. This is not a step-by-step method for
managing change but, instead is an iterative model that relies on the skills and knowledge of the
manager who is bringing about change. For example, the manager may create a series of shortterm wins in order to build guiding teams. During periods of change managers must deal with
staff emotions that can work to undermine attempts at promoting change. Kotter’s model
provides tools to turn negative feelings into positive proactive feelings such as faith, trust,
optimism, urgency, reality-based pride, passion, excitement, hope, and enthusiasm – which are
emotions that promote change (Campbell, 2020). Kotter’s change management model is being
used to address anticipated team resistance to change and to support implementation of this
project.
AIM Statement
The Chlamydia Screening Improvement Project (CSIP) aims to increase the
chlamydia screening rate at a federally qualified healthcare center in California, from a
baseline of 14% to 60% in sexually active females aged 24 and younger over a 12-month
period. CSIP will utilize an electronic notification system within the EMR, aim to
increase staff awareness, provide staff education to increase confidence, and develop a
feedback system to facilitate improvement.
Context
A needs assessment was completed at a federally qualified healthcare center (FQHC) in
California hosting 12 providers and evaluated chlamydia screening rates for the high-risk
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populations of females aged 13 to 24 years old. For the year 2019 screening rates for chlamydia
were found to be 14%. Stakeholders were contacted and verbalized readiness in supporting
practice change. This project leveraged research that shows a multi-faceted approach may be
effective, including medical alerts reminding providers, targeted education for the providers, as
well as medical assistants to help overcome barriers related to provider lack of time and capacity
(Kong et al., 2011). Previously, the FQHC site functioned with an older electronic medical
record system (CernerÒ) but, this older system did not include provisions for notification or
reminders. The electronic medical record system changed to EPICÒ in May 2019 and provision
were included that allowed for configurable notification reminders.
Major stakeholders in this project included the patient, care provider, medical
assistant, and management team within the FQHC. Patients have a pivotal role within the
project as their care is being affected and enhanced through implementation of the
project. The FQHC serves an area of California with one of the lowest public safety
opportunity indexes, lowest life expectancies, and a higher-than-average percentage of
low socio-economic and minority population (Haley, Zimmerman, Woolf, & Evans,
2012). High risk patients who are unaware of an asymptomatic infection can be
identified and treated resulting in improved health and wellness. Care providers include
the medical doctors as well as nurse practitioners, and they are responsible for managing
primary care to the patient population. CSIP affects them directly as they received the
intervention of the project, and subsequently provide the necessary orders to screen this
patient population. Medical assistants are front line workers in this FQHC site and are
involved with the many aspects of patient care. As it relates to this project, they provided
the chlamydia testing kit to the patient as well as education on how to prepare and
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provide the test sample. The management team at this FQHC is responsible for
developing and maintaining policies within the organization. In addition, they also drive
expectations, meet company goals, maintain financial responsibility, and improving
operations within the organization. CSIP stands to impact the management team by
improving screening benchmarks, financial reimbursement, and performance metrics
within the organization.
Proposed Intervention
CSIP is a multi-faceted quality improvement protocol targeting the screening of sexually
active females aged 24 years old and younger within the primary care setting of an FQHC in
California. The project includes education, inclusion of an electronic notification system, and
establishment of appropriate follow-up.
Education is vital to the success of the project and supports facilitating change within the
organization. The educational component of this protocol included a PowerPoint presentation
that disseminated relevant information to key stakeholders of the healthcare team, including
current screening rates, prevalence of asymptomatic infection, risks of untreated infection, nature
of the planned intervention, testing methods, project goals, and important information to be
shared with patients. Key stakeholders receiving the education would include the management
team, treating providers, and medical assistants. Opportunities were planned during education to
illicit questions, concerns, and feedback on the information and project plan. Additionally, the
education component of the project was planned to be recorded and made available as a video to
all employees to view. By doing this we intended to help ensure all stakeholders were privy to
the education component regardless of location, schedule, or availability. The education
component was intended to not only educate, but also to engage and establish urgency with key
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stakeholders of the healthcare team. The educational component helps increase the likelihood of
successful project implementation by way of key stakeholder participation and buy-in.
The inclusion of an electronic notification system was the functional change driving the
project. By adding an electronic notification system, busy care providers were reminded that
chlamydia screening is recommended for this patient, and it occurs upon opening the patient’s
electronic medical record. This allowed providers to minimize distractions regarding
comprehensive care and focus on chief complaint. A benefit of this notification system was that,
in addition to notifying the primary provider, it also notified care team members such as medical
assistants. This facilitates team-based care, allows medical assistants to proactively obtain
specimens and provides the possibility of having medical assistants place chlamydia screening
orders per protocol.
The electronic medical record system at this FQHC transitioned from CernerÒ to EPICÒ
and the functionality was activated as part of the transition to the EPICÒ platform. In its
primary implementation the notification was listed on the front page of the patient chart as a
hyperlink entitled “Healthcare Maintenance”. This link appears in the chart when healthcare
maintenance is due on the patient. By clicking on the link providers are taken to a page where a
comprehensive list of applicable healthcare maintenance is provided. When no healthcare
maintenance is due the hyperlink is not provided. Examples of other comprehensive healthcare
maintenance that may be listed include alcohol abuse screening, breast cancer screening, cervical
cancer screening, cholesterol screening, diabetes screening, depression screening, influenza
vaccine, pneumococcal vaccine, TDAP vaccine, varicella zoster vaccine, and many more.
Establishing appropriate follow-up is an important component for effective chlamydia
screening and treatment. Provided that screening results are negative, a telephone-based or email
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notification would be appropriate. Care must be taken to avoid leaving voice messages with
medical information (including test results) as this might violate HIPAA, thus voicemails should
have a standardized message asking for a return call. In the case that screening identifies a
positive test result (presence of infection), a follow-up appointment should be made with a telehealth appoint being a viable option. This appointment serves to notify the patient of the positive
test results, educate on pathology of disease as well as treatment, ordering of appropriate
treatment for the patient as well as sexual partner, and scheduling a follow up appointment in
three months to ensure reinfection does not occur.
We established that all female patients aged 24 and younger have annual reminders
provided to the primary care providers for chlamydia screening. Thus, the proposed intervention
is an electronic notification reminder within the electronic medical record system. The current
standard is no electronic reminder, where providers are tasked with manually looking up if
patients in this targeted population are due for screening.
SWOT Analysis
At the time of the needs assessment the primary care clinic was transitioning electronic
medical record systems, from CernerÒ to EPICÒ. As such, one of the strengths of this project is
that it was very easy to implement and required only management buy-in for the electronic
notification system to be an activated feature on roll-out. The leveraging and use of enhanced
technology to improve efficiencies of care within a primary care setting is also a strength of this
project. Finally, the staff at this clinical site has a good amount of experience, with low attrition
rate, and this consistency and established teamwork will strengthen the success of this project.
Weaknesses in the project include the need for additional time within a busy primary care
setting where appointments are normally 15 minutes in length and great efforts already exist to
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avoid running behind on appointment schedules. Corporate policies within a primary care clinic
setting can help to establish standards of care and prevent harm but also serve to limit
adaptability within a quickly changing environment and can potentially weaken the long-term
impact of this project. There are many different types of screening for different populations
within a primary care setting, and transitioning to a new notification system will activate all
notifications, thus providers will initially be inundated with potentially multiple screening
notifications for each patient. This can result in notification fatigue which may increase the
chances providers will initially ignore notifications and this will serve to weaken the project.
Opportunities refer to external influences that can benefit, or be benefitted by the project.
An area of opportunity with this project is the increasing education and dissemination of
knowledge regarding chlamydia screening, testing, and treatment. As the site of the project is a
multi-center non-profit organization there is the opportunity for business development through
increased reimbursement by expanding the project throughout the organization. There is also the
opportunity for business development as the components of the project bundle can be readily
adapted to improve other screening needs. Examples of this might include depression, smoking,
obesity, HIV, etc.
Threats to the project can come from social and cultural influences in the community, as
patients may see chlamydia screening at taboo, be uncertain how to talk about it with family or
partners, and may choose to avoid the matter all-together. The political and economic landscape
includes former President Trump policy and funding changes to reduce healthcare coverage for
underserved populations which threatens the sustainability of the project. The current healthcare
focus is on the Covid-19 pandemic which has resulted in the increase of tele-health visits with a
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decreased number of in-clinic appointments, which threatens the impact of this project. A
summary and graphic representation of the SWOT analysis can be found in Appendix B.
Cost Benefit Analysis and Return on Investment (ROI)
The Centers for Disease Control and Prevention state the direct medical cost for
chlamydia, including diagnosis and treating chlamydia-associated infertility, are estimated at
$701 million annually (CDC, 2011). Given that the majority of infections are asymptomatic,
establishing a cost benefit analysis relies on a combination of data and estimates, and data on the
topic is limited. First, not every case of chlamydia infection will result in comorbidity.
According to Herzog et al., (2012) the estimated fraction of chlamydia infected women that
develop into pelvic inflammatory disease is 10% (95% CI, 7-13%). Second, a value needs to be
associated with each case of PID. Based on research by Chesson, Collins, & Koski, (2008) the
average medical costs of each case of PID were $1,995, which included the costs of care for
acute PID and costs associated with sequelae such as chronic pelvic pain, ectopic pregnancy, and
infertility. Finally, data is required on the incidence of chlamydia within the United States.
According to the Centers for Disease Control and Prevention, in 2018 there 1,758,668 reported
cases of chlamydia in the U.S. but an estimated 2.86 million infections occur annually (CDC,
2016). Assuming females account for 50% of the population there would be 1.43 million
infections that occur annually in females. With PID occurring in 10% of these 1.43 million
annual infections, the incidence of PID resulting from chlamydia results in 143,000 cases
annually. As the cost of each case of PID is estimated at $1,995, and the incidence is 143,000,
the net cost of failing to screen for chlamydia is estimated to be in excess of $285 million dollars
annually.
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The Fruitvale neighborhood of Oakland California lies within Alameda County and has
total population of 50,294 (Wikipedia, 2021). Assuming 50% of the population is female it can
be estimated that approximately 25,147 females live within the community surrounding Native
American Health Center. According to Healthy Alameda County website, a source of population
data and community health information provided by the Alameda County Public Health
Department, the prevalence of chlamydia within the county is 584.5 per 100,000 people (2019).
Therefore, an estimated 147 cases of chlamydia occur annually in females living within the
community surrounding NAHC. As PID occurs in 10% of these 147 cases, and a cost of $1,995
per case to treat, an estimated total cost of treating PID in this community can be calculated as
$29,326.50 per year (Appendix I).
There are no direct financial up-front costs associated with CSIP. Secondary costs
include the cost of time for developing educational material, surveys, project oversight, and
compensating staff for completing education and survey time. At a rate of $60 per hour (typical
clinic physician rate) and an estimated time of 16 hours for development, secondary costs are
estimated to be $960. Estimating six physicians at $60 per hour and six medical assistants at $30
per hour, and a total of 30 minutes for education and survey, the total lost costs in time are
estimated to be $5,400. Thus, total project costs are estimated to be $6,360.
GANTT Chart Narrative
A GANTT chart (Appendix E) was used to outline the workflow and milestones for
CSIP. The total project length was 18 months from the initial need’s assessment, illustrated in
the GANTT chart, and began upon approval of the stakeholders. Pre-intervention data was pulled
from the prior 12-month period and referenced while research is conducted and the electronic
notification component of the project is implemented. After a 12-month period data was pulled
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again and reviewed to assess the impact of the electronic notification. A pre-education survey
was developed and distributed to assess a baseline level of knowledge and confidence by clinic
staff. The educational component of CSIP was then developed and provided to all staff
members. The process of development, distribution, and completion of the education component
took approximately 4 months. A post-education survey was then distributed to assess the posteducation level of knowledge and confidence by clinic staff. Once the survey was completed,
data was pulled again and reviewed to assess the impact of the electronic notification in
combination with the educational piece of the project. Finally, a post-project debriefing was
conducted to review results of the data, assess the impact of the project on overall screening
rates, and provide an opportunity for feedback, evaluation, and improvements.
Outcome Measures
The primary outcome for this project is an increase in chlamydia screening rates for
sexually active females aged 24 years old and younger from 14% to 60%. Baseline data was
from the previous EMR that included a review of the targeted patients by age seen over the time
period from May 2018 through May 2019, and compared to the total number of orders for
chlamydia screening over the same time period. After implementing the interventions, screening
rate data was analyzed through the EPICÒ EMR system over a one-year period, from May 2019
through May 2020. Data reflecting screening rates to identify how the use of reminders built
within the electronic medical record system affected screening rates.
Secondary outcomes were measured include provider increase in knowledge, comfort,
and ease of enacting chlamydia screening. A general review of the process including workflow
and response was analyzed. Lastly, identification of possible barriers to increasing screening
rates was reviewed through this intervention.
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Analysis Methods
Analyzing the effects of this project on screening rates for chlamydia consisted of a
comprehensive review that included 1) assessing care team understanding and knowledge of
chlamydia, 2) evaluating providers response to the protocol, 3) evaluating rates of testing, 4)
evaluating the identification of infection caught through screening, 5) and performing a
secondary analysis of why patients did not complete testing.
A pre and post knowledge survey was used to assess the care team’s knowledge and
comfort level surrounding chlamydia screening. Post project provider satisfaction with the
workflow and intervention was assessed to distinguish any issues. The care team included
medical assistants (MA’s) who served to provide initial contact with the patient, provide
specimen collection kits to patients, facilitate initial questions regarding screening, and provide
discharge instructions which include ensuring all questions have been answered. The survey was
provided to assess knowledge and comfort pre and post intervention, and served as valuable
information for assessing the educational component of the protocol.
A survey was also used to assess providers satisfaction with implementation of the
project protocol. Primary care providers are responsible for ordering screening tests, making the
recommendation for screening, addressing patient concerns surrounding screening, educating on
the details of infection as well as answering all patient questions. The CSIP addressed gaps in
knowledge as well as inspired confidence with initiating conversation and enable the
recommended screening for high-risk patients. Results from this survey were used to assess the
impact of the educational component of this protocol. In addition, it provided subjective input as
to the implementation of the electronic notification used within the protocol.
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Data reports were available via software that were generated from the two electronic
medical record systems used, one pre and one post intervention, that identified patients being
screen for chlamydia. These data included filters for female patients, aged 13 to 24 years, with
chlamydia testing performed as either urine, vaginal, or cervical, being performed over the oneyear periods specified, including any provider, and occurring at the clinic location. The search
criteria identified the targeted population, established the total population, determined if each
patient had an annual chlamydia screening performed, and a percentage of the total target
population who had screening completed could be calculated.
Reports were also available via software than be generated from the two electronic
medical record systems used, one pre and one post intervention, that identified patients who were
found to have a chlamydia infection. These reports included filters for female patients, aged 13
to 24 years, with chlamydia testing performed as either urine, vaginal, or cervical, being
performed over the one-year periods specified, who were positive for chlamydia, including any
provider, and occurring within the clinic site. The search criteria identified the targeted
population, established the total population of those screened, determined which patient had a
positive chlamydia test result, and a percentage of the total target population who had positive
test results was calculated.

Ethical Considerations
This project is designed to enhance screening rates for chlamydia and this touches on
several ethical topics which will be considered here. Such topics include autonomy, beneficence,
justice, non-maleficence, and veracity (American Nurses Association, 2015).
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Autonomy revolves around maintaining the patient's right to choose what medical care is
provided to them. For chlamydia screening it’s important to recognize that the patient has the
right to choose to not be screened, and while this possibility is in-fact a limitation within this
project, it’s vital to recognize and support the patient’s choice as to what happens to them from a
preventative healthcare standpoint.
Beneficence refers to the act of providing a benefit or doing good for the patient. The
ethical consideration of beneficence is the basis for this project as improved screening rates can
lower infection rates, reduce comorbidities, and benefit the overall health and wellness of the
community.
In its broadest sense Justice refers to the idea of people getting what they deserve, and
when considered through the lens of morality may also be seen as “what we owe each other”.
Distributive justice is a subset of justice that applies to distributing goods or services of various
kinds to individuals. Improving screening rates for chlamydia is not only a “just” act in that we
owe the opportunity for health and wellness to each other but, this project also enhances
distributive justice in ensuring that screening opportunities are distributed to underserved and
minority populations.
Non-maleficence is the ethical principle that ensures that we “do no harm” to others.
When considering non-maleficence, we have to evaluate the risks involved with screening
patients for chlamydia. In addition to the risks of physical harm, we also address the risks of
psychological, social, and emotional harm. Screening for chlamydia does pose risks for
emotional distress stemming from the fear, anxiety, and embarrassment of testing and the
possibility of being infected. There is also the risk of social harm, despite great strides in
protecting patient privacy, that the patient may share details of testing with family or friends and
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how they may be viewed by their support system. It’s important to highlight that this patient
population includes adolescents and this stage of development emphasizes the acceptance of
family and friends.
Veracity is the ethical principle that addresses honesty and truthfulness in
communication. Within that healthcare setting, and as it relates to this project, veracity is the
comprehensive, accurate, and objective sharing of information as well as ensuring the patient’s
understanding of that information. As it relates to screening for chlamydia, the consideration of
veracity translates to ensuring that this patient population is informed of recommendation for
screening, made aware of the risks and benefits, and have all questions answered honestly and
based on current evidence.
The University of San Francisco Jesuit values are reflected within CSIP. These values
include Cura Personalis (care for the whole person), being people for others, and diversity in all
its forms (University of San Francisco, 2021). By striving to identify and prevent disease, we
serve to care for the physical person while simultaneously caring for the whole person through
commitment to autonomy and respect for individual values. This project has helped to
demonstrate a calling to consider, help, and provide a service to everyone. Furthermore, by
implementing this project in an underserved area of California, within an FQHC organization,
and by providing care to all who need it, we are working to serve the diversity of the community.
Patient confidentiality was honored, participants screening data was anonymous, and all
aspects of HIPPA was monitored throughout the CSIP. Both Cerner and EPIC are HIPPA
compliant EMR systems and data collected on screening rates did not include patient
identification information. All human subject research projects require Institutional Review
Board (IRB) review, regardless of funding. The CSIP involved only analysis of data or
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specimens and is not a research project, but instead a quality improvement project. The intent of
CSIP is to identify and control a problem, or improve a program/service. CSIP is to the benefit
of the participant and participants community, the data that was collected was used to assess and
improve a problem/program/service, the knowledge collected is not generalized beyond the
scope of the activity, and there were no experimental activities conducted, thus CSIP does not
constitute a research project and IRB review was not required.
Results
A total of 312 high-risk patients were identified for screening between 6/17/19 and
6/17/20 (referred to as 2020), following the implementation of this project. A review of the same
patient population for year prior, between 6/17/18 and 6/17/19 (referred to as 2019), revealed a
total of 285 patients. This translates to a 9.4% increase in the total population of high-risk
individuals for chlamydia infection, for this location between 2019 and 2020. The number of
people screened for chlamydia in 2019 was 40 out of 285 total patients and equals a 14%

Chlamydia Screening
350
300
250
200
150
100
50
0

312

285
156

Total Screened

following the implementation of
CSIP, the number of people screened
for chlamydia increased to 156 out of

40

2019

screening rate. For 2020, the year

312 total patients and equals a 50%
2020
Total Patients

Figure 1 – Screening results

screening rate (Figure 1). This
translates to a 256% increase over the
prior year. The Pre-Intervention

survey was sent out through email on 9/7/2020 and a total of 12 participants completed it. The
educational intervention was provided as a PowerPoint Presentation and sent through email to
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staff on 9/23/2020. A total of 6 participants completed the post-Intervention survey which was
provided on 9/30/2020. There were 7 questions in the survey, a Likert scale was used to quantify
data, the value of 1 representing a strong positive response and 5 representing a strong negative
response (Appendix J). Thus, data with a mean value closer to 1 equates to more confidence and
knowledge in the area, while a mean value closer to 5 reflects low confidence and knowledge.
The Standard Deviation refers to the variability of the distribution of data. Thus, a Standard
Deviation closer to 0 indicates everyone answered very similarly, while a higher standard
deviation indicates participants had great variability in their answers. The same questions were
used for both the pre- and post-analysis.
Table 1 – Education Pre- and Post- Survey Data
Survey Questions
Pre-Survey Data
Mean
Standard
Deviation
I am comfortable discussing
1.50
0.50
chlamydia with a patient
I know what the most common
1.83
0.90
symptoms of chlamydia are
I can identify the high-risk population
2.17
0.99
for chlamydia infection
I am aware of who should be screened
1.67
1.11
for chlamydia regularly
I understand how to test for chlamydia
1.42
1.11
I know how to treat chlamydia
infection
I understand how to address sexual
partners and testing for cure

Post-Survey Data
Mean
Standard
Deviation
1.50

0.50

1.50

0.50

2.00

1.41

2.00

1.41

1.33

0.47

1.83

1.14

1.33

0.47

1.92

0.95

1.83

0.69

Results of survey data are summarized in Table 1 and reveal that prior to the education
module staff members were on average most comfortable with the topics of how to test for
chlamydia (mean=1.42) followed by being comfortable discussing chlamydia with a patient
(mean=1.50). After the education module was completed, survey data shows that providers
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remained most comfortable with the topic of how to test for chlamydia (mean=1.33), but now
also includes how to treat chlamydia infection (mean=1.33). The pre-survey questions with the
least confidence included identifying high risk populations (mean=2.17) followed by addressing
sexual partners and testing for cure (mean=1.92). After the education module was completed
survey data revealed that staff members continued to be least comfortable with the questions of
identifying high-risk population for chlamydia screening (mean=2.00), in addition to identifying
who should be screened regularly (mean=2.00).
The education module was created using a PowerPoint format and was developed to
share current knowledge as well as reinforce understanding of the different aspects of chlamydia
care, including symptoms, screening, and treatment modalities. Objectives for the module
included that by the end of the module participants would be able to describe what chlamydia
infection is, explain typical symptoms, identify high-risk populations, describe guidelines for
screening/testing, understand current methods for screening, explain how treatment is provided,
and identify special considerations of care. Information was provided from the Centers for
Disease Control and Prevention as well as several evidence-based research articles, with one
slide dedicated for expanding on each of the objectives. The intent of the information was to be
clear and concise, and contained 11 slides in total. As a result of Covid-19 and the shelter-inplace order, the intended plan for in-person education had to be modified to a remote learning
format. The education content was converted to an Adobe PDF file to facilitate ease of web
browser viewing, and provided to the organization. The organization emailed all providers and
when providing the email introduced the project, providing the pre-survey link, the education
component as an attachment, and the post-survey link.
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The survey questions were designed to elicit understanding and confidence levels for

each of the areas of the education module. Questions are unchanged between the pre- and postsurvey in order to directly compare the effects of the education intervention on the providers.
Each question is reviewed in greater detail and the results are interpreted for impact and
effectiveness.
Question 1 – I am comfortable discussing chlamydia with a patient.
The first question gauges general overall comfort level for providers while discussing the
topic of chlamydia with patients.
Survey Questions
I am comfortable discussing
chlamydia with a patient

Pre-Survey Data
Mean
Standard
Deviation

Post-Survey Data
Mean
Standard
Deviation

1.50

1.50

0.50

0.50

The mean score was 1.5 for the pre-survey with 6 providers (50%) stating they felt “very
comfortable” discussing chlamydia with patients and 6 providers (50%) stating they felt
“somewhat comfortable”. The post-survey mean score was also 1.5, with 3 providers (50%)
stating they felt “very comfortable” discussing chlamydia with patients and 3 providers (50%)
stating they felt “somewhat comfortable”. The standard deviation of 0.50 for both pre- and postsurvey demonstrate low variability and high consistency in the answers. The information from
this survey questions suggests that providers are comfortable with talking about the subject of
chlamydia with their patients, and that the education module had no impact on the provider’s
level of comfort.
Question 2 – I know what the most common symptoms of chlamydia are.
The second question queries knowledge regarding what the most common symptoms of
chlamydia a patient would experience. Research indicates that most chlamydia infections have
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no symptoms, and for those that do have symptoms the most common symptoms are vaginal
discharge and a burning sensation when urinating.
Survey Questions
I know what the most common
symptoms of chlamydia are

Pre-Survey Data
Mean
Standard
Deviation

Post-Survey Data
Mean
Standard
Deviation

1.83

1.50

0.90

0.50

The second question asks about how well they know the most common symptoms of
chlamydia. The mean score was 1.83 on the pre-survey with 5 providers (41.67%) stating they
“strongly agree”, 5 providers (41.67%) stating they “somewhat agree”, 1 provider (8.33%)
stating “neither agree or disagree” and 1 provider (8.33%) stating “somewhat disagree”. The
mean score was 1.50 on the post-survey with 3 providers (50%) stating they “strongly agree” and
3 providers (50%) stating they “somewhat agree”. The standard deviation of 0.90 in the presurvey, lowering to 0.50 in the post-survey suggests that there was a higher variability in
knowledge levels but the education module resulted in knowledge of common symptoms
becoming much more consistent. This survey data suggests that the education module helped to
improve understanding of common symptoms of chlamydia. However, it’s also possible that the
2 participants who provided low confidence in the pre-survey may not have completed the postsurvey.
Question 3 – I can identify the high-risk population for chlamydia infection.
The third question asks how well the provider can identify high-risk populations for
chlamydia infection. Research shows that the most high-risk populations for chlamydia infection
are sexually active females aged 13 to 24 years old.

Survey Questions

Pre-Survey Data

Post-Survey Data
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I can identify the high-risk
population for chlamydia
infection

Mean

Standard
Deviation

Mean

Standard
Deviation

2.17

0.99

2.00

1.41

The mean score was 2.17 on the pre-survey with 2 providers (16.67%) who “strongly
agree”, 8 providers (66.67%) who “somewhat agree”, 1 provider (8.33%) who “neither agree or
disagree”, and 1 provider (8.33%) who “strongly disagree”. The mean score was 2.00 on postsurvey with 3 providers (50%) who “strongly agree”, 2 providers (33.33%) who “somewhat
agree”, and 1 provider (16.67%) who “strongly disagree”. The standard deviation of 0.99 on
pre-survey, increasing to 1.41 on post-survey indicates that participant answers became less
consistent after the education. Survey data suggests that providers are not as comfortable with
identifying high-risk populations for chlamydia as they are with discussing chlamydia. As the
number of providers who “strongly agree” rose in the post-survey, from 2 to 3, it further suggests
that there was improvement in knowledge from the education. However, the same number of
providers who “strongly disagree” continued to strongly disagree after the education module.
This may suggest that providers had questions about the information, did not understand the
information, or did not agree with the information.
Question 4 – I am aware of who should be screened for chlamydia regularly.
The fourth question asks how well providers know who should be screened for chlamydia
on a regular basis. Research demonstrates that the high-risk population is the group who should
be screened regularly for chlamydia.
Survey Questions
I am aware of who should be
screened for chlamydia regularly

Pre-Survey Data
Mean
Standard
Deviation

Post-Survey Data
Mean
Standard
Deviation

1.67

2.00

1.11

1.41
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The mean score was 1.67 on the pre-survey with 8 providers (66.67%) who “strongly
agree”, 2 providers (16.67%) who “somewhat agree”, and 2 providers (16.67%) who “somewhat
disagree”. On post-survey, the mean score was 2.00 with 3 providers (50%) who “strongly
agree”, 2 providers (33.33%) who “somewhat agree”, and 1 provider (16.67%) who “strongly
disagree”. Standard deviation rose from 1.11 to 1.41 in the post-survey indicating that not only
did providers feel less comfortable knowing who should be screened for chlamydia, they were
also less consistent with their self-assessments. This question resulted in a worsening mean
score after the education module, suggesting that the education module either confused providers
or they disagreed with the information. Likely, the lower score is partially caused by the lower
overall number of providers reporting, in combination with 1 provider who reported feeling less
confident about who should be screening for chlamydia then before the education.
Question 5 – I understand how to test for chlamydia.
The fifth question gauges how well providers know what the testing options are when
screening or testing for chlamydia. Research demonstrates that the best method to test for
chlamydia is a urine sample using the first part of the urine (first catch urine).
Survey Questions
I understand how to test for
chlamydia

Pre-Survey Data
Mean
Standard
Deviation

Post-Survey Data
Mean
Standard
Deviation

1.42

1.33

1.11

0.47

The mean score was 1.42 on the pre-survey with 10 providers (83.33%) who “strongly
agree”, 1 provider (8.33%) who “somewhat agree”, and 1 provider (8.33%) who “strongly
disagree”. On post-survey, the mean score was 1.33 with 4 providers (66.67%) who “strongly
agree”, and 2 providers (33.33%) who “somewhat agree”. This question resulted in an improved
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mean score suggesting the education module helped increase providers knowledge and comfort
level with testing options for chlamydia screening. Standard deviation improved from 1.11 on
the pre-survey to 0.47 on the post-survey, indicating participants were also more consistent with
their knowledge and level of comfort regarding chlamydia testing.
Question 6 – I know how to treat chlamydia infection.
The sixth question evaluates how well providers know how to treat chlamydia infection.
Research demonstrates that the standard treatment for chlamydia consists of a one-time dose of
azithromycin at a dose of 1 gram.

Survey Questions
I know how to treat chlamydia
infection

Pre-Survey Data
Mean
Standard
Deviation

Post-Survey Data
Mean
Standard
Deviation

1.83

1.33

1.14

0.47

The mean score was 1.83 on pre-survey with 6 providers (50%) who “strongly agree”, 4
providers (33.33%) who “somewhat agree”, 1 provider (8.33%) who “neither agree or disagree”,
and 1 provider (8.33%) who “strongly disagree”. On post-survey the mean score was 1.33 with
4 providers (66.67%) who “strongly agree” and 2 providers (33.33%) who “somewhat agree”.
This question resulted in an improved mean score suggesting the education module helped
increase provider knowledge and comfort level with how to treat chlamydia infection. Standard
deviation improved from 1.14 on the pre-survey to 0.47 on the post survey indicated providers
were also more consistently comfortable with knowing how to properly treat chlamydia
infection.
Question 7 – I understand how to address sexual partners and testing for cure.
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The seventh question evaluates provider knowledge related to medically supporting
sexual partners as well as how/when a provider would test to confirm the infection is cured.
Research demonstrates that the providers may order treatment for sexual partners without an
office visit, that patient and partner should refrain from sex for 7 days after treatment, and that
because the rate of reinfection is so high retesting should occur after 3 months.
Survey Questions
I understand how to address
sexual partners and testing for
cure

Pre-Survey Data
Mean
Standard
Deviation

Post-Survey Data
Mean
Standard
Deviation

1.92

1.83

0.95

0.69

The mean score was 1.92 on pre-survey with 5 providers (41.67%) who “strongly agree”,
4 providers (33.33%) who “somewhat agree”, 2 providers (16.67%) who “neither agree nor
disagree”, and 1 provider (8.33%) who “somewhat disagree”. On post-survey the mean score
was 1.83 with 2 providers (33.33%) who “strongly agree”, 3 providers (50%) who “somewhat
agree”, and 1 provider (16.67%) who “neither agree nor disagree”. This question resulted in
improved mean score suggesting the education module helped increase provider knowledge and
comfort level with addressing the sexual partners of patients with chlamydia infection as well as
testing for cure. Standard deviation also improved from 0.95 on the pre-survey to 0.69 on the
post-survey indicated providers felt more consistent in their knowledge and understanding of
how to address sexual partners and chlamydia retesting.
For this project the electronic notification system had a strong effect on screening rates
over the one-year period, resulting in an increase from 14% to 50%. Konerman et al. (2017)
implemented a similar notification system in order to screen for Hepatitis C in high-risk
populations and demonstrated an increase from 7.6% to 72% over a one-year period.
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Furthermore, Tapp et al. (2020) incorporated a notification system within a large healthcare
system, including 12 primary care practices, and saw increases in screening rates for both
Hepatitis C (3.2% to 22.7%) as well as HIV (6.2% to 11.3%). The utilization of electronic
notification systems in the literature has consistently shown beneficial results and the use of this
intervention to address chlamydia screening demonstrated similar and significant positive results.
The goal of this project was to increase screening rates to at least 60% and there are
several potential reasons for not reaching this goal. The goal was broken down to consist of 50%
coming as a result of the electronic notification system and 10% coming from the educational
component; a review of the educational survey data demonstrates minimal to no effect in
chlamydia knowledge for providers which suggests the educational intervention or the survey
methods needs review and improvement. The electronic notification system was activated at the
same time as a number of other screening notifications, potentially resulting in something which
can be referred to as notification overload. During implementation of EPIC, previous screening
and vaccination information was not incorporated, leaving providers inundated and requiring
manually addressing multiple screening notifications for each and every patient. As patients
often come with a primary complaint, providers are often faced with the option of cancelling the
reminder and foregoing the appropriate screening test. This can happen for a number of reasons;
providers may be running behind schedule, the patient may have several complaints or be a
complex patient, or the provider may just prioritize one of screening needs (i.e., depression).
Thus, future projects might benefit by addressing notification overload such as allocating
resources to ensure screening and vaccination data is imported from previous EMRs, manually
entered and updated prior to activation, or giving providers the option to reset the notification so
that it notifies them again at the next appointment.
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Discussion
Despite a review of national data that shows screening for chlamydia in the high-risk
population is occurring at a rate of approximately 50%, an assessment performed at an FQHC
providing primary care to underserved populations in California demonstrated screening rates to
be at 14%. During project research and development, the incorporation of an electronical
notification system within the medical record was identified as a useful method to bring
screening rates close to national averages, while the inclusion of knowledge sharing and
education strongly suggested that screening rates could be boosted at least temporarily above
national averages. Thus, the aim of this project was to improve screening rates for chlamydia in
high-risk populations from 14% to at least 60% within a 12-month period, and as this project
resulted in an overall increase of 50%, we did not successfully achieve our goal.
Key findings from this project included that the incorporation of an electronic notification
system resulted in significant increases to screening rates, independent of supportive activities
such as education modules, collecting surveys, and raising awareness. This aspect of the
intervention contributed most importantly to the success of the overall change seen in this
project. An unexpected and key finding came from the survey data which demonstrated areas of
minimal improvements to knowledge and confidence. More surprising was that one of the
questions, related to identifying who should be screened for chlamydia regularly (i.e., identifying
high-risk populations), resulted in less knowledge and lower confidence after the education. We
assume that these results occurred as a result of education material that was not presented in a
clear and concise manner, without follow-up, discussion, or question and answer. Staff likely
had preconceived notions, misinformation, or questions regarding high-risk populations for
chlamydia screening, and the education module did not provide enough information.
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Anecdotally, it was observed that a type of notification overload was occurring during the project
and this was neither considered or prepared for. Numerous electronic notifications were
activated simultaneously upon software release as the incorporation of screening history into the
new EMR never occurred. Therefore, each patient arriving in clinic would have an average of 6
electronic notifications including depression, smoking, and obesity. To resolve this properly the
provider would have to open the old charting system alongside the new system, evaluate each
notification and update the new system accordingly. The issue of notification overload could
have been avoided through the incorporation of historic screening information into the new EMR
or through the organization’s establishing each patient’s initial visit after implementation of the
EMR as a 30-minute visit to provide ample time for providers to update charts manually in realtime.
An important implication from this project for the advanced nursing practice is that
routinely assessing organizational outcomes can help identify gaps in care, and can reveal
opportunities to improve patient outcomes. This project began through a need’s assessment,
where data on a number of communicable diseases was assessed and compared against
guidelines as well as national averages. An additional implication is that the use of a notification
system within the electronic medical record has benefit that translates beyond chlamydia and can
be incorporated for any number of evolving and currently identified screening criteria. This
solution could also benefit other recommended screening guidelines such as obesity, depression,
other sexually transmitted infections, and cancer as well as to remind providers about
recommended vaccinations. Such a system could be centrally updated to reflect changes in any
of the guidelines, such as the American Cancer Society’s recent change for colorectal cancer
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screening in men, to lower the age for screening to begin at 45 years old (American Cancer
Society, 2021).
Providing an educational component for staff member, including chlamydia knowledge,
screening guidelines, and treatment modalities can be beneficial for raising awareness and
keeping staff updated of potentially evolving changes in the standards of practice. Results from
this project’s survey data shows that the educational component of this project had a minimal
and potentially negative impact on improving self-reported provider knowledge or confidence in
certain aspects of screening and treating this population.
The use of an electronic notification system in combination with staff education has been
suggested in literature as an effective method for raising awareness while increasing screening
rates for a number of diseases within the primary care setting. This solution was incorporated,
modified for fit, form and function, and implemented within a primary care setting to enhance
chlamydia screening. The results of this project demonstrate that screening rates can be
significantly increased by use of this intervention bundle, though staff education and selfconfidence was only minimally impacted.
Next steps for this project involve expanding to other clinic sites in order to provide
strength to and validate the effects of the intervention. Additionally, the educational component
of the project could be reviewed, revised, and re-evaluated utilizing video conferencing or inperson sessions for improved effect.
Interpretations
The purpose of this project was to enhance awareness and knowledge regarding
chlamydia, and to implement a solution that will lead to improved screening rates in high-risk
populations. Despite survey data suggesting that minimal improvements to chlamydia
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knowledge were realized after the educational intervention, an interpretation of the design of the
education material as well as the robustness of the survey data collection should be considered.
The most successful outcome of this project came from evaluating the percentage of people who
are being screened for chlamydia after implementing the intervention. Post-intervention
screening rates more than tripled, and now align with national screening rate data suggesting the
project was effective.
In evaluating the survey data there is a noted lack of safeguards in place to ensure that
access to the post-intervention survey was only available to 1) those who completed the preintervention survey and 2) those who watched the educational intervention. While there is no
evidence that this occurred, it was possible for new participants, as well as those who did not
complete the educational intervention, to access the post-intervention survey and provide data
which could have skewed results. To address this shortcoming, a recommendation would be to
assign randomized identification numbers to participants, a feature available in the Qualtrics
survey software, which validates consistency with participants, allowing for more granularity in
the review of data and leading to a better understanding of the true effect of this intervention.
Alternatively, the educational intervention could have been completed in person as a presentation
and included both a participation sheet as well as a question-and-answer period to reinforce the
education. Shelter-in-place orders resulting from Covid-19 would have made this an unlikely
solution. Additionally, the lower than anticipated turnout in post-survey respondents (n=6)
limits the generalizability of the results.
Limitations
The greatest limitation to this project came about as a result of the Covid-19 pandemic
which reached the United States in 2020 and reshaped the primary healthcare landscape.
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According to the County of Alameda, shelter-in-place orders were issued to the general public
starting March 16, 2020 and had an emphasis on staying at home, leaving only for vital services,
and maintaining social distancing (County of Alameda, 2020). Shortly after shelter-in-place
order were issued this primary care clinic site was able to incorporate technology for the purpose
of facilitating tele-health patient visits. While this allowed for the management of chronic
conditions and addressing of new complaints, the ability to facilitate ongoing healthcare
screenings is unknown. According to Alexander et al. (2020), primary care visits decreased by
21.4% during the second quarter of 2020. One could infer there were also less labs and
screening tests ordered to allow for better focus on patient complaints during this time. As data
for the project was collected up through June 2020, a resulting three months of information based
on telehealth visits is included, and has likely impacted the results of this project. The
significance of this impact is unclear.
An obstacle to the effective rollout of the CSIP was related to notification overload, the
large number of notifications within the EMR that occur during the workday, and the impact it
would have on the effectiveness of this project. According to a 2016 article in Healthcare IT
News, information overload is a concern because new types of notifications can be easily created
within the electronic medical record (McCarthy, 2016). As a result, practitioners are
experiencing notifications both asynchronously (inbox-like format) and synchronously (pop-up
messages) for an increasing number of care related activities, including screenings, vaccinations,
test results, response to referrals, requests for medication refills, and messages from other
healthcare professionals. Future research would benefit from measuring the impact notification
overload has on effective electronic notification as well as systems that may help address it. One
approach to addressing this limitation may be having the electronic medical record automatically
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enter the appropriate screening order when triggered by electronic notification and allowing the
provider to manually cancel the order if the patient chooses to forgo screening.
Perhaps an extenuating condition of the observed notification overload is that
practitioners within the primary care setting are not provided additional time or compensation for
addressing notifications, with the required time and efforts caused by these notifications not
being accounted for. Within the primary care location of this project, the organizational business
plan allocates 15-minute time slots for appointments in order to support patient’s primary
complaint. In addition to addressing primary complaints, providers also perform a review of
systems, elicit a medical history, address all pertinent notifications, address any secondary
complaints, and answer questions. In practice, providers are becoming more often left to
prioritize aspects of care within appointment time frames and the true potential of novel ideas
such as electronic notifications could be limited by a lack of time.
Conclusion
Screening for disease in at-risk populations is an effective method to reduce comorbidity
and improve health and wellness within the community. However, there are a number of
challenges for screening in a busy primary care setting, with additional challenges existing for
screening adolescents and young adults. Several organizations have developed evidence-based
guidelines that call for annual screening to identify chlamydia infection for sexually active
females aged 13 to 24 years old. While organizations strive for 100% screening, data shows that
primary care is averaging approximately 50% screening rates nation-wide. Within an FQHCbased primary care clinic site, operating in an underserved area of Oakland CA, screening rates
were found to be at 14%. By implementing a bundle that includes an electronic notification
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system with education module, screening rates for this high-risk population were shown to
improve to 50%, which brings this clinic screening rates in line with the national average.
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Appendix C.1 – Research Evaluation Table
Citation
Keegan, M., 2014,
Journal of Clinical
Outcomes
Management,
Volume 21, Issue 1,
pp 30-38

Aims
To review current
chlamydia
screening
recommendations,
screening tests,
barriers to
screening, and
management of
infection.

Design &
Methodology
Screening –
Randomized
controlled trial and
cluster randomized
trial
Testing – One
analysis comparing
different screening
strategies.
Barriers – One
survey and two
studies.
Management – Two
meta-analyses.

Sample & Setting
Screening –
N = 2607 high risk
women
1,009 had
intervention
1,598 received no
intervention
N = 17 high school
8 high schools had
intervention
9 high schools had
no intervention
Testing – Cell
culture, NAAT,
direct
immunofluorescence,
enzyme
immunoassay, and
nucleic acid
hybridization testing
were evaluated.
Barriers – Two
studies from the
Contraceptive
CHOICE Project.

Variable
Screening –
Screening and
treatment versus
usual care.
Schools in the
intervention group
received the
education material
and offer for free
testing.
Testing – sensitivity
and specificity
Barriers – Not
applicable.
Management –
Other antibiotics
including
doxycycline,
erythromycin, and
fluoroquinolones.

Measurement &
Analysis
Screening –
P-value
Risk ratio
Confidence interval
Testing –
Sensitivity
Specificity
Barriers –
Risk ratio
Confidence interval
Management –
P-value
Confidence interval

Findings
Screening – The
USPSTF adopted
annual screening
based on the
evidence of these
studies.
Testing – Use of
NAAT technology
offers superior
sensitivity and
allows for vaginal
swab and urine
testing.
Barriers – Included
a lack of
knowledge and
stigma.
Treatment – 1 gram
of Azithromycin
PO once is
effective at treating
infection.

Management – 2002
meta-analysis as well
as CDC
recommendations.
(RCT = Randomized Controlled Trial, USPSTF = United States Preventative Services Task Force, NAAT = Nucleic Acid Amplification Test, PO = oral
administration)
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Appendix C.2 – Research Evaluation Table
Citation
Guy, R., 2011,
BMC Infectious
Disease, Volume
11, Article 211, pp
1-13

Aims
To provide an
updated synthesis of
studies examining
the efficacy of
interventions to
improve chlamydia
screening.

Design &
Methodology
Systematic review
of articles from
PubMed, Medline,
EMBASE,
Cochrane, and
Australian New
Zealand Clinical
Trial Registry
Key words included
chlamydia, testing
or screening,
intervention or trial,
and general practice
or primary care.

Sample & Setting
96 total articles
were identified
81 articles were
excluded based on
exclusion criteria
15 articles were
included for review

Variable
Study outcomes
included clinic
screening rates,
total tests done, and
mean number of
tests per physician.

Measurement &
Analysis
Six of the 15
articles were
significantly
associated with
increased
chlamydia
screening at a Pvalue of 0.05.

Findings
Interventions for
increasing
screening in female
population:
Multi-faceted
quality
improvement
program.
Linking screening
to a PAP smear.
Integration of
computer alerts.
Funding for free
sexual health visits.
An interactive
educational
workshop.
An internet-based
education program
for doctors
promoting
screening in highrisk female
population.

(PAP = Papanicolaou smear)
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Appendix C.3 – Research Evaluation Table
Citation

Aims

McDonagh, L.,
2018,
Implementation
Science, Volume
13, Article 130, pp
1-19

To identify barriers
and facilitators to
chlamydia testing
for young people in
general practice,
and to map these
onto the COM-B
model.

Design &
Methodology
Systematic Review
of seven databases
including
MEDLINE,
PubMed, Embase,
Informit, Web of
Science,
PsycINFO, and
Scopus.
The Capability,
Opportunity,
Motivation,
Behavior (COM-B)
is a theory of
behavior that can
provide insight into
chlamydia testing
behavior.

Sample & Setting

Variable

Articles from
January 2000
through April 2018.

A standardized
framework was
used to record aims,
methodological
characteristics,
theoretical
framework, main
findings, and
conclusion of each
study.

Eligible studies had
to explore
facilitators and/or
barriers to
chlamydia testing,
views toward
testing, and/or
acceptability of
testing in general
practice.
39 papers met
including criteria
14 focused on
patients
25 focused on
providers

(MA = Medical Assistant, RN = Registered Nurse)

COM-B lies at the
center of the
Behavior Change
Wheel, a toolkit for
designing behavior
change
interventions, and
is a starting point
for intervention
development.

Measurement &
Analysis
Each paper was
assessed using the
Critical Appraisal
Skills Programme
(CASP) by two
reviewers.
Thematic analysis
was performed to
identify prominent
themes.
Identified themes
were then classified
into six subcomponents of the
COM-B model.

Findings
Barriers
Lack of knowledge
Lack of awareness
Forgetfulness
Perceived risk
Embarrassment
Fear
Stigma
Difficult to discuss
No MA/RN
involvement
Time constraints
Facilitators
Information/education
Belief in
responsibility
Concern for infection
Training/use of
scripts
Alternative modes of
testing
Involving MA/RN
Normalization
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Appendix C.4 – Research Evaluation Table
Citation

Aims

Wong, W., 2019,
Epidemiologic
Reviews,
Volume 41, Issue 1,
Pages 168 -175,

To evaluate
chlamydia
screening
interventions and
address issues
related to the
heterogeneity of
interventions which
makes it difficult to
determine which
are effective.

Design &
Methodology
Systematic Review
of databases
including PubMed,
Cochrane Library,
the British Nursing
Index, Medical
Database, and
Sociological
Abstracts via
ProQuest.

Sample & Setting
Articles published
in English after
2000.
Interventions had to
focus on chlamydia
screening and have
one or more of the
following outcome
measures: number
of chlamydia tests,
testing rate,
retesting rate,
and/or treatment
rate for chlamydia
200 studies met
inclusion criteria
21 reviews were in
the final inclusion

Variable
Variables include
target populations,
settings, type of
testing, number of
people tested,
prevalence, number
of people treated,
effectiveness, and
barriers.

Measurement &
Analysis
A socioecological
model was used to
organize
interventions into
categories
including
interpersonal,
organization,
community, and
policy

Findings
Interpersonal
Home-based selfcollection kits
Organizational
Computer alerts for
doctors
Community
Screening in
educational and
detention centers
Policy
Educational package
among general
practitioners
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Appendix C.5 – Research Evaluation Table
Citation

Aims

McNulty, C., 2013,
Sexually
Transmitted
Infections,
Volume 90, Issue 3,
Pages 188-194

To determine if a
structured complex
intervention
increases
chlamydia
screening in a
general practitioner
practice.

Design &
Methodology
A prospective,
cluster randomized
controlled trial with
modified Zelen
design.
Practices may tend
to participate in
educational
initiatives, making
research practice
atypical
The modified Zelen
design overcomes
potential bias by
not informing any
participants that
they participating
in a trial.

(GP = General Practice)

Sample & Setting

Variable

160 different
general practice
settings in
Southwest England
between 2009 and
2011.

The complex
intervention
includes an
outreach
educational
workshop
(presentation) with
combination of
posters, invitation
cards, and
electronic
reminders.

80 practices to
intervention and 80
to control.
Intervention is
based on the theory
of planned behavior
consisting of
education and
practical resources
to influence social
cognition in staff
and increasing
testing intention.

Measurement &
Analysis
Aggregate data by
month, age and
gender for each
registered GP on all
chlamydia
screening tests in
the study area were
used to assess the
absolute and
relative change in
testing between the
intervention,
control, and nonstudy practices.

Findings
Testing rates across
all practices with the
intervention saw an
increase from 2.43 to
4.34 per 100 patients,
compared to the
control group with
saw an increase from
2.43 to 3.00 per 100
patients.
The complex
intervention led to a
76% increase in
screening rates across
all practices.
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Appendix C.6 – Research Evaluation Table
Citation

Aims

Karas, D., 2018,
Clinical Pediatrics,
Volume 57, Issue
14,
Pages 1638 -1641

To identify the
impact of a CDS
tool on the
screening rates for
chlamydia among
female patients
aged 13 to 21 years
presenting in
preventative care.

Design &
Methodology
A retrospective
review evaluating
the impact of popup alerts and
education on
chlamydia
screening rates over
an 18-month
period.

Sample & Setting
Akron Children’s
Hospital Pediatrics
is a network of 27
pediatric primary
care offices in
urban, suburban,
and rural areas.
All practices are
linked through a
common EHR
(EPIC)
Participants were
females between
the ages of 13 and
21 years old.

(CDS = Clinical Decision Support, EHR = Electronic Health Record)

Variable
A pop-up alert to
notify providers
that a patient was
due for screening.
An educational
component was
also developed in
conjunction to
increase providers
awareness of
screening
recommendations,
consisting of two
presentations and
quarterly
newsletters
distributed to the
medical offices for
2 years

Measurement &
Analysis
An evaluation of
medical record
information looking
at how many alerts
occurred, how
many declined
screenings, had
screening
performed at
another facility, or
consented to
screening.

Findings
The proportion of
screened patients
increased from 230 to
561 which represents
a 109% increase
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Appendix C.7 – Research Evaluation Table
Citation

Aims

Ursa, A., 2019,
Chinese General
Practice, Volume
22, Issue 25, Pages
3028 - 3034

The aim of this
paper is to conduct
a case study
looking at the use
of Plan-Do-CheckAdjust (PDCA) as
a framework for
quality
improvement to
improve chlamydia
screening in
women aged 16 to
24 years old

Design &
Methodology
Plan, Do, Check,
Adjust model and
the Model for
Improvement steps.

Sample & Setting

Variable

Part of a multidepartment
collaboration
(family medicine,
internal medicine,
pediatrics,
obstetrics and
gynecology, and
the University
Health Service)
within the
University of
Michigan Health
System, over a oneyear period from
May 2014 to May
2015.

Education material
and a clinical
decision support
tool within the
EHR.

Eligible patients
were women aged
16 – 24 who were
sexually active.

(PDCA = Plan, Do, Check, Adjust, EHR = Electronic Health Record)

The educational
material was for
staff, patients, and
parents that
explained the
importance of
screening, the
process of
screening, and
notification of
results and
treatment.
The clinical
decision support
tool was an alert
that displayed in an
area of the EHR
called “best
practice advisory”.

Measurement &
Analysis
Data collection
included outputs
from the EMR as
well as interviews
with clinicians and
staff to understand
the current state
and challenges of
chlamydia
screening.

Findings
Screening improved
from 29% to 60%
within 8 months at the
pilot clinic site.
Four years after the
intervention screening
rates ranged from
32% - 63% for 16 to
17 years old and 49%
- 80% for 18 to 24
years old
QI projects benefit
from the step-by-step
process outlined in
the PDCA and Model
for Improvement
theories to effectively
tackle challenges and
improve outcomes.
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Appendix D – Gap Analysis
Chlamydia Screening Improvement Project Gap Analysis
Current State

Best Practice

Proposed Solution

Potential lack of staff knowledge
regarding aspects of chlamydia screening
and treatment, as well as potential lack of
confidence to effectively discuss and
answer questions with patients

Provide periodic and updated chlamydia
education to staff members including
screening guidelines, symptoms,
treatment, and common questions

Develop education module for staff to
teach and update knowledge regarding
chlamydia screening and treatment

Cultural and educational barriers to
effective chlamydia screening in the
clinical setting

Staff to effectively communicate and
educate patients, answer questions about,
and recommend annual screening for
high-risk patients

Create survey for staff members to
measure knowledge and confidence in
discussing chlamydia in the clinic setting,
both pre and post education

Absence of formal system to remind
providers of high-risk population and
frequency for chlamydia screening

Availability of a convenient and
accessible reminder system for staff to
identify high-risk populations and
chlamydia screening guidelines

Initiate electronic notification/reminder
system to alert providers when clinic
patients are considered high-risk and due
for screening
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Appendix E – GANTT Chart

Perform needs assessment
Pull initial pre-intervention
clinic data
Research
Propose intervention bundle
Stakeholder approval
Implement electronic
notification system
Perform data analysis
Conduct pre-survey
assessment
Develop and provide
education component
Perform data analysis
Provide post-survey
assessment
Post-project debriefing

Apr

Mar

Feb

Jan

Dec

Nov

Oct

Sep

2021

Aug

Jul

Jun

May

Apr

Mar

Feb

Jan

Dec

Nov

Oct

Sep

2020

Aug

Jul

Jun

May

Apr

Mar

Feb

Jan

Dec

Nov

2019

Oct

Sep

Aug

Jul

Jun

Project Event

May

2018
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Appendix F – Work Breakdown Structure
Level 1
1. Chlamydia Screening
Improvement Project (CSIP)

Level 2
1.1 Initiation

Level 3
1.1.1 Evaluation of Baseline Data & Recommendations
1.1.2 Develop the Business Case
1.1.3 Develop the Project Charter

1.2 Planning

1.2.1 Create Aim Statement
1.2.2 Determine Project Team
1.2.3 Define Electronic Notification and Test in Virtual “Playground”
1.2.4 Develop Education Module and Survey Material
1.2.5 Develop Project Plan
1.2.6 Project Plan Approval

1.3 Execution

1.3.1 Project Kickoff Meeting
1.3.2 Implement Software System Upgrade
1.3.3 Evaluate Electronic Notification in Real-Time
1.3.4 Test Report System for Accumulation of Data Verification
1.3.5 Conduct Pre-Survey
1.3.6 User Training / Education
1.3.7 Conduct Post-Survey
1.3.8 Evaluation of Post-Intervention Data

1.4 Closeout

1.4.1 Project Review Meeting
1.4.2 Document Project Plan with Results and Lessons Learned
1.4.3 Update Files/Records
1.4.4 Gain Formal Acceptance
1.4.5 Archive Files/Documents

71

72

INCREASING CHLAMYDIA SCREENING IN PRIMARY CARE
Appendix G - SWOT Analysis

STRENGTHS
- Easy to implement
- Good staff experience
- Uses technology

OPPORTUNITIES
- Increase education
- Corporate expansion
- Business development

WEAKNESSES
- Takes more time
- Policy limitations
- Notification fatigue

THREATS
- Socio-cultural impact
- Political/economic
effects
- Covid-19
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Appendix H – Communication Matrix

Site Coordinator

Clinic Site
(Native American Health
Center)
Author

Chair

(Michael Barnett)

(Dr. Jodie Sandhu)

Primary Care
Providers

Registered Nurses

Medical Assistants
Second Chair
(Dr. Chris Balkissoon)
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Appendix I – Cost Analysis
Direct Expense
Development
Education Module
Survey
Activate electronic reminders

Projected Cost (-)

Project Savings (+)

$480
$480
$0

Training
Education
Survey
Total Projected Costs
Indirect Costs
Treatment for PID
Estimated annual # of cases
Total Projected Savings
(Net Cost / Savings)

$2,700
$2,700
$6,360
$1,995
147
$29,326.50
+ $22,966.50
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Appendix J – Chlamydia Screening Improvement Project Pre and Post Survey
1. I am comfortable discussing chlamydia with a patient
(Strongly Agree) 1 2 3 4 5 (Strongly Disagree)
2. I know what the most common symptoms of chlamydia are
(Strongly Agree) 1 2 3 4 5 (Strongly Disagree)
3. I can identify the high-risk population for chlamydia infection
(Strongly Agree) 1 2 3 4 5 (Strongly Disagree)
4. I am aware of who should be screened for chlamydia regularly
(Strongly Agree) 1 2 3 4 5 (Strongly Disagree)
5. I understand how to test for chlamydia
(Strongly Agree) 1 2 3 4 5 (Strongly Disagree)
6. I know how to treat chlamydia infection
(Strongly Agree) 1 2 3 4 5 (Strongly Disagree)
7. I understand how to address sexual partners and testing for cure
(Strongly Agree) 1 2 3 4 5 (Strongly Disagree)
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